BWM
DGX icon

BerganKDV Wealth Management’s Quest Diagnostics DGX Stock Holding History

BerganKDV Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$151K Sell
1,071
-44
-4% -$6.07K 0.02% 250
2023
Q1 		$158K Buy
1,115
+44
+4% +$6.29K 0.02% 256
2022
Q4 		$168K Sell
1,071
-514
-32% -$73.9K 0.02% 246
2022
Q3 		$194K Hold
1,585
– – 0.02% 230
2022
Q2 		$211K Hold
1,585
– – 0.02% 239
2022
Q1 		$217K Buy
1,585
+1,058
+201% +$147K 0.02% 238
2021
Q4 		$91K Buy
+527
New +$80.2K 0.01% 343

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BerganKDV Wealth Management's DGX Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Quest Diagnostics (DGX) stake by 3.9% in Q2 2023, selling an estimated $6.07K and leaving 1,071 shares worth $151K. The position accounts for 0.02% of the portfolio, ranked #250.

BerganKDV Wealth Management first reported a position in DGX in Q4 2021 and has held it in 7 quarters since. The position peaked at $217K in Q1 2022. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • BerganKDV Wealth Management held 1,071 shares of Quest Diagnostics worth $151K as of Q2 2023.
  • BerganKDV Wealth Management sold 44 Quest Diagnostics shares in Q2 2023, an estimated $6.07K.
  • Quest Diagnostics made up 0.02% of BerganKDV Wealth Management's portfolio in Q2 2023, its #250 holding.
  • BerganKDV Wealth Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 7 quarters since.
  • BerganKDV Wealth Management's Quest Diagnostics position peaked at $217K in Q1 2022.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.